BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 316485)

  • 1. "Pre-B" phenotypes in blast crisis of Ph1 positive CML: evidence for a pluripotential stem cell "target".
    Greaves MF; Verbi W; Reeves BR; Hoffbrand AV; Drysdale HC; Jones L; Sacker LS; Samaratunga I
    Leuk Res; 1979; 3(4):181-91. PubMed ID: 316485
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane marker analysis of 'lymphoid' and myeloid blast crisis in PH1 positive (chronic myeloid) leukemia.
    Janossy G; Greaves MF; Capellaro D; Roberts M; Goldstone AH
    Haematol Blood Transfus; 1977; 20():97-107. PubMed ID: 305406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of "lymphoid" phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of Ph1 positive leukemia.
    Janossy G; Woodruff RK; Pippard MJ; Prentice G; Hoffbrand AV; Paxton A; Lister TA; Bunch C; Greaves MF
    Cancer; 1979 Feb; 43(2):426-34. PubMed ID: 283875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near haploid cell line in lymphoid blast crisis of Ph1-positive chronic myeloid leukemia.
    Kessous A; Colombies P; Pris J; Clement D
    Cancer Res; 1980 Apr; 40(4):1354-9. PubMed ID: 6928400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological characterization of normal and leukemia-associated antigens of acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.
    Mohanakumar T; Miller DS; Anderson J; Metzgar RS
    Cancer Res; 1978 Mar; 38(3):716-22. PubMed ID: 75058
    [No Abstract]   [Full Text] [Related]  

  • 6. The chromosomes and causation of human cancer and leukemia. XVIII. The missing Y in acute myeloblastic leukemia (AML) and Ph1-positive chronic myelocytic leukemia (CML).
    Sakurai M; Sandberg AA
    Cancer; 1976 Aug; 38(2):762-9. PubMed ID: 1067892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomy 7 and multipotential stem cell transformation.
    Chan LC; Sheer D; Drysdale HC; Bevan D; Greaves MF
    Br J Haematol; 1985 Nov; 61(3):531-9. PubMed ID: 3864487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia.
    Janossy G; Roberts M; Greaves MF
    Lancet; 1976 Nov; 2(7994):1058-61. PubMed ID: 62904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ph1-positive leukaemia, including chronic myelogenous leukaemia.
    Rowley JD
    Clin Haematol; 1980 Feb; 9(1):55-86. PubMed ID: 6245823
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological typing of blast cells. Cases with pre-B cell characteristics.
    Noworolska A; Kościelniak E; Brodzka W; Harłozińska A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):1-7. PubMed ID: 6202592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomes and causation of human cancer and leukemia. XXV. Significance of the Ph1 (including unusual translocations) in various acute leukemias.
    Oshimura M; Sandberg AA
    Cancer; 1977 Sep; 40(3):1149-60. PubMed ID: 332321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomes and causation of human cancer and leukemia. XXXII. Unusual features of Ph1-positive acute myeloblastic leukemia (AML), including a review of the literature.
    Abe S; Sandberg AA
    Cancer; 1979 Jun; 43(6):2352-64. PubMed ID: 378356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Philadelphia chromosome positive human leukaemia cell line (NALM-1) with pre-B characteristics.
    Minowada J; Koshiba H; Janossy G; Greaves MF; Bollum FJ
    Leuk Res; 1979; 3(4):261-6. PubMed ID: 316486
    [No Abstract]   [Full Text] [Related]  

  • 14. B cell markers in Ph1-positive acute lymphoblastic leukemia.
    Alimena G; De Rossi G; Gastaldi R; Guglielmi C; Mandelli F
    Nouv Rev Fr Hematol (1978); 1980; 22(3):275-80. PubMed ID: 6970921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of "lymphoid" and myeloid cases.
    Janossy G; Greaves MF; Revesz T; Lister TA; Roberts M; Durrant J; Kirk B; Catovsky D; Beard ME
    Br J Haematol; 1976 Oct; 34(2):179-92. PubMed ID: 788772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can chromosome Ph1 be regarded as the marker of the neoplastic multivalent lympho-hematopoietic stem cell?].
    Rupniewska ZM; Rozynkowa D; Kowal M
    Postepy Hig Med Dosw; 1984; 38(1):39-60. PubMed ID: 6387685
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of chromosomes 8, 9, 19 and 22 in PH1 positive and PH1 negative chronic myelocytic leukemia in the chronic or blastic stage.
    Gahrton G; Lindsten J; Zech L
    Acta Med Scand; 1974 Nov; 196(5):355-60. PubMed ID: 4531216
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenotype-related chromosome aberrations and stem cell involvement in acute myeloid leukemia.
    Castoldi G; Cuneo A; Tomasi P
    Haematologica; 1989; 74(6):525-9. PubMed ID: 2697674
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin gene organisation and expression in haemopoietic stem cell leukaemia.
    Ford AM; Molgaard HV; Greaves MF; Gould HJ
    EMBO J; 1983; 2(6):997-1001. PubMed ID: 6416836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.